TapewireFind a company

person · Reporting owner

JIMENEZ JOSEPH

Disclosed activity across 5 companies

Tapewire entity
10709
SEC CIK
0001199095

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
General Motors CoGM · Entity 2958DirectorDecember 31, 2025January 05, 2026
LENZ Therapeutics, Inc.GRPH · Entity 6475DirectorJuly 19, 2023July 21, 2023
PROCTER & GAMBLE CoPG · Entity 2814DirectorOctober 13, 2026October 14, 2026
Quantinuum Inc.QNT · Entity 3437DirectorJune 04, 2026June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

General Motors Co

Report date December 31, 2025 · Filed January 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Share Units ("DSUs")SEC Table II · derivative / convertible securityDirect89,247 Reported balance After 2025-12-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-12-31 · Grant · Acquired 6,172 · Balance 89,247

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Deferred Share Units ("DSUs")SEC Table II · derivative / convertible securityDirect90,111 Reported balance After 2025-12-31 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2025-12-31 · Grant · Acquired 864 · Balance 90,111

F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year.

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Filing footnotes · ownership attribution and instrument terms

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year.

LENZ Therapeutics, Inc.

Report date July 19, 2023 · Filed July 21, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.72 · Expires 2033-07-18Direct20,000 Reported balance After 2023-07-19 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2023-07-19 · Grant · Acquired 20,000 · Balance 20,000

F1: The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.

PROCTER & GAMBLE Co

Report date October 13, 2026 · Filed October 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect38,967.634 Reported balance After 2026-10-13 transaction · row 1
1 source row

Row 1 · 2026-10-13 · Grant · Acquired 1,438 · Balance 38,967.634

F1: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

Quantinuum Inc.

Report date June 04, 2026 · Filed June 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect72,498 Ending reported balance After 2026-06-05 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-06-04 · Grant · Acquired 5,833 · Balance 5,833

F1: Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock. The RSUs will vest in three equal annual installments beginning on June 5, 2027.

Row 2 · 2026-06-05 · Purchase · Acquired 66,665 · Balance 72,498

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock. The RSUs will vest in three equal annual installments beginning on June 5, 2027.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Century Therapeutics, Inc.

Report date June 12, 2025 · Filed June 16, 2025

Section 16 reporting ended · disclosed 2021-06-21. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.60 · Expires 2035-06-12Direct44,000 Reported balance After 2025-06-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-06-12 · Grant · Acquired 44,000 · Balance 44,000

F1: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 09, 2021 Filed Mar 10, 2021 19:00 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 238 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010023 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,524.194

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
January 14, 2021 Filed Jul 1, 2021 23:00 UTC LENZ Therapeutics, Inc. GRPH · Entity 6475 Exercise / conversionStock Option (right to buy) · Derivative 49,876 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0000899243-21-027013 · doc4.xml · derivative · entry 4

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49,876 shares

Expires 2031-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of June 24, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.

F2 · derivative.underlying_shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

Read SEC document
January 14, 2021 Filed Jul 1, 2021 23:00 UTC LENZ Therapeutics, Inc. GRPH · Entity 6475 Exercise / conversionCommon Stock 49,876 $0.30 $14,962.80
Disclosure

SEC source: 0000899243-21-027013 · doc4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F2 · price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F2 · balance_after: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

Read SEC document
January 13, 2021 Filed Jul 1, 2021 23:00 UTC LENZ Therapeutics, Inc. GRPH · Entity 6475 GrantStock Option (right to buy) · Derivative 49,876 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0000899243-21-027013 · doc4.xml · derivative · entry 3

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,876

Underlying: Common Stock · 49,876 shares

Expires 2031-01-12

F2 · derivative.exercise_price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of June 24, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.

F2 · derivative.underlying_shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

F2 · balance_after: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:44 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 866 $18.32 $15,865.12
Disclosure

SEC source: 0001467858-21-000010 · wf-form4_160988307845413.xml · derivative · entry 2

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,863

Underlying: Common Stock · 866 shares

Expires not disclosed

F4 · security: Represents dividends accrued on DSUs in 2020 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan.

F2 · derivative.exercise_price: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F5 · price: The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable dividend payment date.

F2 · derivative.exercise_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F2 · derivative.expiration_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:44 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 9,678 $30.48 $294,985.44
Disclosure

SEC source: 0001467858-21-000010 · wf-form4_160988307845413.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,997

Underlying: Common Stock · 9,678 shares

Expires not disclosed

F1 · security: Deferred Share Units ("DSUs") were awarded pursuant to the General Motors Company Deferred Compensation Plan for Non-Employee Directors (the "Plan"). Under the Plan, each non-employee director is required to defer one-half of the $305,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more.

F2 · derivative.exercise_price: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F3 · price: The price of the DSUs is the average closing price of the Company's Common Stock during the previous calendar year.

F2 · derivative.exercise_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F2 · derivative.expiration_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Read SEC document
December 08, 2020 Filed Dec 9, 2020 20:31 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 254 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-030977 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,231.878

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
October 13, 2020 Filed Oct 14, 2020 18:49 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 1,387 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026895 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,931.091

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

Read SEC document
September 08, 2020 Filed Sep 9, 2020 18:58 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 258 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-024822 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,544.091

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
June 09, 2020 Filed Jun 10, 2020 19:44 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 296 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019339 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,246.442

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:37 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 249 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010388 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,905.563

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 21:56 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 1,451 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-20-000012 · wf-form4_157808858095475.xml · derivative · entry 2

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,319

Underlying: Common Stock · 1,451 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · price: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · derivative.exercise_date: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · derivative.expiration_date: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 21:56 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 7,987 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-20-000012 · wf-form4_157808858095475.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,868

Underlying: Common Stock · 7,987 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Read SEC document
December 10, 2019 Filed Dec 12, 2019 15:20 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 388 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-034860 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,619.999

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
October 08, 2019 Filed Oct 10, 2019 20:30 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 1,654 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-030375 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,196.533

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

Read SEC document
September 10, 2019 Filed Sep 11, 2019 18:35 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 261 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-028184 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,542.533

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
June 11, 2019 Filed Jun 12, 2019 18:49 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 252 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-021451 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,257.43

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 15:16 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 225 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-011309 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,980.773

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
December 31, 2018 Filed Jan 3, 2019 22:33 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 1,095 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-19-000021 · wf-form4_154655480436025.xml · derivative · entry 2

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,881

Underlying: Common Stock · 1,095 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · price: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · derivative.exercise_date: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

F2 · derivative.expiration_date: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date.

Read SEC document
December 31, 2018 Filed Jan 3, 2019 22:33 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 7,538 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-19-000021 · wf-form4_154655480436025.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,786

Underlying: Common Stock · 7,538 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Read SEC document
December 11, 2018 Filed Dec 12, 2018 19:19 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 293 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-036043 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,732.061

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
October 09, 2018 Filed Oct 11, 2018 18:15 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 2,129 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-029972 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,416.401

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

Read SEC document
September 11, 2018 Filed Sep 12, 2018 18:44 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 336 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-027393 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,287.401

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
June 12, 2018 Filed Jun 14, 2018 17:26 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 357 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-020864 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,947.189

F1 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 21:03 UTC PROCTER & GAMBLE Co PG · Entity 2814 GrantCommon Stock 121 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-011587 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,589

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 23:40 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 726 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-18-000007 · wf-form4_151502281015541.xml · derivative · entry 2

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,248

Underlying: Common Stock · 726 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F2 · derivative.exercise_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.expiration_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 23:40 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 7,578 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-18-000007 · wf-form4_151502281015541.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,522

Underlying: Common Stock · 7,578 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

Read SEC document
December 31, 2016 Filed Jan 5, 2017 00:18 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 454 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-17-000017 · wf-form4_148357548159237.xml · derivative · entry 2

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,944

Underlying: Common Stock · 454 shares

Expires not disclosed

F2 · security: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.exercise_price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.exercise_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.expiration_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

Read SEC document
December 31, 2016 Filed Jan 5, 2017 00:18 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 7,980 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-17-000017 · wf-form4_148357548159237.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,490

Underlying: Common Stock · 7,980 shares

Expires not disclosed

F1 · security: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.